"Regionale Schwerpunktversorgung auf hohem Niveau im akademischen Lehrkrankenhaus der Johannes Gutenberg-Universität Mainz."

During the past decade, Klinikum Idar-Oberstein conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Idar-Oberstein" #1 sponsor was "Aesculap AG" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Jurgen Barth" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "University Hospital, Essen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Idar-Oberstein" #1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Idar-Oberstein" are "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials), "Craniotomy" (1 trials), "Duraplasty" (1 trials), "Follicular Lymphoma" (1 trials) and "Hairy Cell Leukemia (HCL)" (1 trials). Many other conditions were trialed in "Klinikum Idar-Oberstein" in a lesser frequency.

Most popular intervention types in "Klinikum Idar-Oberstein" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "2CdA +/- Rituximab" (1 trials), "ASA 100 mg" (1 trials), "Lyoplant Onlay" (1 trials), "VELCADE" (1 trials) and "dabigatran etexilate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Idar-Oberstein" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Idar-Oberstein". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Klinikum Idar-Oberstein, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Idar-Oberstein, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".